Drug Holidays and Overall Survival of Patients with Metastatic Colorectal Cancer

Drug Holidays and Overall Survival of Patients with Metastatic Colorectal Cancer

Different de-escalation strategies have been proposed to limit the risk of cumulative toxicity and guarantee quality of life during the treatment trajectory of patients with metastatic colorectal cancer (mCRC). Programmed treatment interruptions, defined as drug holidays (DHs), have been implemented...

Full description

Bibliographic Details
Main Authors: Silvio Ken Garattini, Debora Basile, Marta Bonotto, Elena Ongaro, Luca Porcu, Carla Corvaja, Monica Cattaneo, Victoria Josephine Andreotti, Camilla Lisanti, Elisa Bertoli, Giacomo Pelizzari, Donatella Iacono, Gianmaria Miolo, Giovanni Gerardo Cardellino, Angela Buonadonna, Giuseppe Aprile, Gianpiero Fasola, Fabio Puglisi, Nicoletta Pella
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Cancers
Subjects:
metastatic colorectal cancer
treatment strategies
drug holidays
maintenance
Online Access:https://www.mdpi.com/2072-6694/13/14/3504

Internet

https://www.mdpi.com/2072-6694/13/14/3504

Similar Items